Kuhnil to launch Omaco, a triglyceride lowering therapy.
The company said that Omaco was developed by Pronova, a Norway company, under the U. S. FDA approval as the first therapeutic drug containing omega-3 fatty acid as a main active ingredient, wh...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
